Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot-to-lot consistency study of intradermal inactivated influenza vaccine in adults
2006-002369-37Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of influenza vaccine (split virion, inactivated) in influenza (4 arms), sponsored by Sanofi. Primary endpoint: Anti-hemagglutinin antibody titers at Day 21 for each influenza strain. Started Jun 2006; status: completed.
02
Drugs
influenza vaccine (split virion, inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002369-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002369-37.